Oxaliplatin News and Research

RSS
New approach can prevent aggressive operation in certain rectal cancer patients

New approach can prevent aggressive operation in certain rectal cancer patients

Study shows how Cisplatin chemotherapy leads to neuronal apoptosis

Study shows how Cisplatin chemotherapy leads to neuronal apoptosis

Immunotherapy benefits patients with gastric and esophageal cancers, new data shows

Immunotherapy benefits patients with gastric and esophageal cancers, new data shows

First clinical trial could become an effective way to deliver chemotherapy to abdominal cancer patients

First clinical trial could become an effective way to deliver chemotherapy to abdominal cancer patients

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program

Trial of cancer drug OxaliTex promises lower toxicity and more robust action

Trial of cancer drug OxaliTex promises lower toxicity and more robust action

NUS researchers identify new protein to prevent chemotherapy-induced neuropathy

NUS researchers identify new protein to prevent chemotherapy-induced neuropathy

Data results of NCI-MATCH trial in tumors with DNA mismatch repair deficiencies

Data results of NCI-MATCH trial in tumors with DNA mismatch repair deficiencies

Innovative compound kills cancer cells, minimizes damage to normal tissues

Innovative compound kills cancer cells, minimizes damage to normal tissues

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park receives more than $15 million in grants for cancer research

Processed aconite root could relieve neuropathic pain in murine peripheral neuropathy

Processed aconite root could relieve neuropathic pain in murine peripheral neuropathy

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer

Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

SLU researchers turn off excruciating chemo pain in animal model

SLU researchers turn off excruciating chemo pain in animal model